Source: Blood. Conference titles: Annual Meeting American Society of Hematology. Unidade: FM
Assunto: HEMATOLOGIA
ABNT
DULLEY, Frederico Luiz et al. Liposomal daunorubicin and dexamethasone (DX) as a treatment for multiple myeloma (MM): the DD protocol. Blood. [S.l.]: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 03 out. 2024. , 1999APA
Dulley, F. L., Saboya, R., Hungria, V. T., Bueno, N. D., Mori, N. S., Mello, F. G., et al. (1999). Liposomal daunorubicin and dexamethasone (DX) as a treatment for multiple myeloma (MM): the DD protocol. Blood. Faculdade de Medicina, Universidade de São Paulo.NLM
Dulley FL, Saboya R, Hungria VT, Bueno ND, Mori NS, Mello FG, Frota MT, Chiattone CS, Jamra MA. Liposomal daunorubicin and dexamethasone (DX) as a treatment for multiple myeloma (MM): the DD protocol. Blood. 1999 ; 94( 10): 315a.[citado 2024 out. 03 ]Vancouver
Dulley FL, Saboya R, Hungria VT, Bueno ND, Mori NS, Mello FG, Frota MT, Chiattone CS, Jamra MA. Liposomal daunorubicin and dexamethasone (DX) as a treatment for multiple myeloma (MM): the DD protocol. Blood. 1999 ; 94( 10): 315a.[citado 2024 out. 03 ]